Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway
Gemcitabine resistance will occur by time after the initial response in pancreatic cancer. Ginkgolide B (GB), a major terpene lactone component of Ginkgo biloba leaves, is a highly selective and competitive inhibitor for platelet-activating factor (PAF) receptor. In the present study, we evaluated t...
Main Authors: | Changjie Lou, Haibo Lu, Zhigang Ma, Chao Liu, Yanqiao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S075333221834664X |
Similar Items
-
The Optimization and Production of Ginkgolide B Lipid Microemulsion
by: Wu Xiao, et al.
Published: (2019-06-01) -
Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p
by: Yi Zhi, et al.
Published: (2016-10-01) -
Preparation of a novel ginkgolide B niosomal composite drug
by: Zhou Juntong, et al.
Published: (2020-08-01) -
Optimizing the Formulation for Ginkgolide B Solid Dispersion
by: Wu Xiao, et al.
Published: (2018-08-01) -
Cardioprotection of Ginkgolide B on Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Regulation of A20-NF-κB Pathway
by: Rui Zhang, et al.
Published: (2018-12-01)